The Indian government has placed the largest order of vaccines so far. According to reports, it is procuring 660 million doses of Covaxin and Covishield the estimated worth of which is 145.05 billion Indian Rupees. This would help it meet the projections it has made
India’s Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US’ National Institute of Health has said. The NIH said results of two studies of blood serum from people who
The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday. There was no dissenting voice among the members of the National Technical Advisory Group on Immunization (NTAGI
The recruitment for the clinical trial of the country’s first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS here from Tuesday. This will be followed by the clinical trial of children in the age-group of 2-6
The Delhi High Court on Wednesday said if the Delhi government could not ensure that people will get both doses of COVAXIN within the stipulated time, then it should not have started so many vaccination centres with “much pomp and splendour”. Justice Rekha Palli issued notice
The government is examining Pfizer’s request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) V K Paul said on Thursday. At a press conference, Paul said, “Yes we are engaged with Pfizer and they
